Smooth Drug Development September 2020 News Release

We were working on the following new projects in September:

• Observational trial is being initiated in dermatology

• We signed a contract for a bioequivalence study (INN: Paracetamol) with long-term sponsor

• Several contracts with international sponsors for PV services were signed

Clinical Department News

• Few projects restarted after COVID-19 pandemic.

• Enrollment finished in phase III trial in arthrosis

• We are preparing for submission in III phase trial in COVID-19

• We did a lot of work in II phase trial in COVID-19: contracts with sites are signing, LEC approvals from first site were received, eCRF development was finished and we are preparing protocol amendment